← FDA DRUG APPROVALS

FDA ANDA · ANDA090724

FLUDARABINE PHOSPHATE

Sponsor: AREVA PHARMS

APPLICATION
ANDA090724
TYPE
ANDA
ORIGINAL APPROVAL
2010-09-27
LATEST ACTION
2023-03-29
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUDARABINE PHOSPHATEPrescription
FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) · INJECTABLE · INJECTION

Approval history

2023-03-29Manufacturing (CMC) · Supplement 6 · unknownReviewAP
2010-09-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →